Welcome to our dedicated page for TOKID news (Ticker: TOKID), a resource for investors and traders seeking the latest updates and insights on TOKID stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect TOKID's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of TOKID's position in the market.
Optima Medical Innovations Corp. has announced a delay in filing its annual financial statements and management discussion and analysis for the year ending December 31, 2021, due to a COVID-19 outbreak affecting its auditors. As a result, the company anticipates missing the May 2, 2022 filing deadline. They expect to submit the required filings by July 1, 2022. Additionally, Optima is applying for a management cease trade order from the Ontario Securities Commission due to this anticipated default. The company confirms no further material developments have occurred since its last financial disclosure.
Optima Medical Innovations Corp. (formerly Tree of Knowledge International Corp.) announces a name change and share consolidation effective November 18, 2021. The share consolidation will be on a 5-for-1 basis, resulting in 47,500,130 common shares outstanding post-consolidation. Trading under the new symbol OMIC will commence at market open. The Canadian Securities Exchange has approved these changes, and no action is required from shareholders. The company emphasizes its commitment to innovative health solutions, focusing on pain management and wellness.
